Capricor Therapeutics CAPR
NASDAQ CAPR
$11.22 +2.35 (+26.49%)
At close: Nov 11, 2026 · 4:00 PM EST

Capricor Therapeutics (CAPR) Other Non-Current Liabilities (2012 - 2013)

Updated

Analysis

Capricor Therapeutics (CAPR) Other Non-Current Liabilities (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Capricor Therapeutics 515.69 Mn -516.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 499,993.00
Jun 30, 2013 512,087.00
Mar 31, 2013 408,842.00
Dec 31, 2012 63,384.00
Jun 30, 2012 190,863.00
API Access

Capricor Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=CAPR&period=max&api_key=YOUR_API_KEY